Howard Colman

44.1k citations

151 papers · 11.8k indexed · 8 hit papers · h-index 46

Impact in

Genetics top 0.05%
- Glioma Diagnosis and Treatment
Cancer Research top 0.2%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics

Papers in

Genetics 106
- Glioma Diagnosis and Treatment 103
Cancer Research 52
- Cancer Genomics and Diagnostics 21
- Cancer, Hypoxia, and Metabolism 20

Co-authors: Adam L. Cohen Kenneth Aldape Burt G. Feuerstein Anjan Misra Janice Nigro Erik P. Sulman Ken Aldape Heidi Phillips
Journals: Journal of Clinical Oncology (39 papers)Neuro-Oncology (25 papers)Journal of Neuro-Oncology (8 papers)Cancer Research (4 papers)Stem Cells (4 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Howard Colman

143 papers receiving 11.6k citations

Hit Papers

8 papers align trajectories log scale

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas 2020 · 310 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2020 Acta Neuropathologica
2018 Acta Neuropathologica
2017 Neurotherapeutics
2015 Neuro-Oncology
2013 Current Neurology and Neuroscience Reports
2011 Cancer Cell
2009 Nature
2006 Cancer Cell

Peers

Countries citing papers authored by Howard Colman

Since Specialization

Citations

This map shows the geographic impact of Howard Colman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Colman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Colman more than expected).

Fields of papers citing papers by Howard Colman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Colman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Colman. The network helps show where Howard Colman may publish in the future.

Co-authors

The 25 scholars most cited alongside Howard Colman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard Colman Line = papers co-authored together Howard Colman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combined inhibition of focal adhesion kinase and RAF/MEK elicits synergistic inhibition of melanoma growth and reduces metastases Cell Reports Medicine ·Jared Almazan, Tursun Turapov, David A. Kircher, Karly A. Stanley, Katie M. Culver, A. Paulina Medellin, MiKaela N. Field, Gennie L. Parkman, Howard Colman, Sílvia Coma, Jonathan A. Pachter, Sheri L. Holmen	2025	2
2	Evaluation of VAL-083 in GBM AGILE, a phase 3 registration platform trial for newly diagnosed and recurrent glioblastoma. Journal of Clinical Oncology ·John Frederick De Groot, Timothy F. Cloughesy, Donald A. Berry, Meredith Buxton, Howard Colman, Benjamin M. Ellingson, Gary Gordon, Andrew B. Lassman, Michael Lim, Ingo K. Mellinghoff, Erik P. Sulman, Michael Weller, Patrick Y. Wen, Emma Maria Viktoria Hyddmark, Tom Mikkelsen, Scott Owen, Warren Mason, Jan Drappatz, Nicholas Blondin, James Perry, (unknown)	2024	0
3	D-TERMINED, a phase 1 trial in newly diagnosed high-grade glioma with temozolomide, radiation, and minocycline followed by adjuvant minocycline/temozolomide Neuro-Oncology Advances ·William Bennion McKean, Jingye Yang, Kenneth M. Boucher, Dennis C. Shrieve, Gita Suneja, Karen L. Salzman, Randy L. Jensen, Howard Colman, Adam L. Cohen	2024	1
4	Subclonal Cancer Driver Mutations Are Prevalent in the Unresected Peritumoral Edema of Adult Diffuse Gliomas Cancer Research ·Hunter R. Underhill, Michael Karsy, Christian J. Davidson, Sabine Hellwig, Samuel Stevenson, Eric A. Goold, Sydney Vincenti, Drew L. Sellers, Charlie Dean, Brion E. Harrison, Mary P. Bronner, Howard Colman, Randy L. Jensen	2024	4
5	The association of diabetes mellitus and routinely collected patient‐reported outcomes in patients with cancer. A real‐world cohort study Cancer Medicine ·Dominik Ose, Emmanuel Adediran, Bayarmaa Mark, Krista Ocier, William A. Dunson, Cindy Turner, Belinda Taylor, Kim Svoboda, Andrew R. Post, Jennifer Leiser, Howard Colman, Cornelia M. Ulrich, Mia Hashibe	2024	1
6	The T Cell Immunoscore as a Reference for Biomarker Development Utilizing Real-World Data from Patients with Advanced Malignancies Treated with Immune Checkpoint Inhibitors Cancers ·Islam Eljilany, Payman Ghasemi Saghand, James L. Chen, Aakrosh Ratan, Martin D. McCarter, John D. Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne M. Arnold, Michelle L. Churchman, Patrick Hwu, José R. Conejo-García, William S. Dalton, George J. Weiner, Issam El Naqa, Ahmad A. Tarhini	2023	5
7	Incorporating long non-coding RNA (lncRNA) into genome-wide biomarker screening for prognostic gene signatures of immunotherapy outcomes. Journal of Clinical Oncology ·Xuefeng Wang, Tingyi Li, Vineeth Sukrithan, Aakrosh Ratan, Martin D. McCarter, John D. Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne M. Arnold, Michelle L. Churchman, Patrick Hwu, William S. Dalton, George J. Weiner, Ahmad A. Tarhini	2023	2
8	Diabetes, Body Fatness, and Insulin Prescription Among Adolescents and Young Adults with Cancer Journal of Adolescent and Young Adult Oncology ·Andreana N. Holowatyj, Richard Viskochil, Dominik Ose, Benjamin Tingey, Benjamin Haaland, Dalton Wilson, Mikaela Larson, Sara Feltz, Mark A. Lewis, Howard Colman, Cornelia M. Ulrich	2020	10
9	cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” Acta Neuropathologica ·Daniel J. Brat, Kenneth Aldape, Howard Colman, Eric C. Holland, David N. Louis, Robert B. Jenkins, Bette K. Kleinschmidt‐DeMasters, Arie Perry, Guido Reifenberger, Roger Stupp, Andreas von Deimling, Michael Weller Hit paper breakdown →	2018	553
10	Development of the Electronic Social Network Assessment Program Using the Center for eHealth and Wellbeing Research Roadmap JMIR Human Factors ·Maija Reblin, Yelena P. Wu, Justin Pok, Lauren Kane, Howard Colman, Adam L. Cohen, Eduardo Mendivil, Echo L. Warner, Miriah Meyer, James Agutter	2017	23
11	Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas Neurosurgical FOCUS ·Ricky Chen, Vijay M. Ravindra, Adam L. Cohen, Randy L. Jensen, Karen L. Salzman, Andrew P. Prescot, Howard Colman	2015	40
12	Clinical course and progression-free survival of adult intracranial and spinal ependymoma patients Neuro-Oncology ·Elizabeth Vera‐Bolanos, Kenneth Aldape, Ying Yuan, Jimin Wu, Khalida Wani, Mary Jo Necesito-Reyes, Howard Colman, Girish Dhall, Frank S. Lieberman, Philippe Métellus, Tom Mikkelsen, Antonio Omuro, Sonia Partap, Michael D. Prados, H. Ian Robins, Riccardo Soffietti, Jing Wu, Mark R. Gilbert, Terri S. Armstrong	2014	88
13	The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma Genes & Development ·Krishna Bhat, Katrina L. Salazar, Veerakumar Balasubramaniyan, Khalida Wani, Lindsey Heathcock, Faith Hollingsworth, Johanna D. James, Joy Gumin, Kristin Diefes, Se Hoon Kim, Alice Turski, Yasaman Azodi, Yuhui Yang, Tiffany Doucette, Howard Colman, Erik P. Sulman, Frederick F. Lang, (unknown), Sjef Copray, Brian Vaillant, Kenneth Aldape	2011	298
14	FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis Cancer Cell ·Nu Zhang, Ping Wei, Aihua Gong, Wen‐Tai Chiu, Hsueh‐Te Lee, Howard Colman, He Huang, Jianfei Xue, Mingguang Liu, Yong Wang, Raymond Sawaya, Keping Xie, W.K. Alfred Yung, René H. Medema, Xi He, Suyun Huang Hit paper breakdown →	2011	473
15	Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments Current Oncology Reports ·Evanthia Galanis, Wenting Wu, Jann N. Sarkaria, Susan M. Chang, Howard Colman, Daniel J. Sargent, David A. Reardon	2010	18
16	Exploratory Analysis of the Copy Number Alterations in Glioblastoma Multiforme PLoS ONE ·Pablo R. Freire, Marco Vilela, Helena Deus, Yong‐Wan Kim, Dimpy Koul, Howard Colman, Kenneth Aldape, Oliver Bögler, W. K. Alfred Yung, Kevin R. Coombes, Gordon B. Mills, Ana Tereza Ribeiro de Vasconcelos, Jonas S. Almeida	2008	32
17	Epidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of Glioblastoma Journal of Clinical Oncology ·Christopher E. Pelloski, Karla V. Ballman, Alfred Furth, Li Zhang, E. Lin, Erik P. Sulman, Krishna Bhat, J. Matthew McDonald, W.K. Alfred Yung, Howard Colman, Shiao Y. Woo, Amy B. Heimberger, Dima Suki, Michael D. Prados, Susan M. Chang, Fred G. Barker, Jan C. Buckner, C. David James, Kenneth Aldape	2007	239
18	Podoplanin expression is an independent predictor of survival in malignant gliomas Cancer Research ·Erik P. Sulman, Christopher E. Pelloski, J. Matthew McDonald, Clarissa De La Cruz, Lihong Long, Sonya Popoff, Susan L. McGovern, Howard Colman, Kenneth Aldape	2007	1
19	Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-β for supratentorial glioblastoma: Results of RTOG 9710 International Journal of Radiation OncologyBiologyPhysics ·Howard Colman, Brian Berkey, Moshe Maor, Morris D. Groves, Christopher J. Schultz, Sandra Vermeulen, Diana F. Nelson, Minesh P. Mehta, W.K. Alfred Yung	2006	45
20	Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma Cancer Research ·Janice Nigro, Anjan Misra, Li Zhang, Ivan Smirnov, Howard Colman, Chandi Griffin, Natalie Ozburn, Mingang Chen, Edward Pan, Dimpy Koul, W.K. Alfred Yung, Burt G. Feuerstein, Kenneth Aldape	2005	261

About Howard Colman

Howard Colman is a scholar working on Genetics, Cancer Research, Oncology, Structural Biology and Biological Psychiatry, having authored 151 papers that have together received 11.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (103 papers), Brain Metastases and Treatment (21 papers), Cancer Genomics and Diagnostics (21 papers), Cancer, Hypoxia, and Metabolism (20 papers), Cancer Cells and Metastasis (16 papers), Cancer Treatment and Pharmacology (11 papers), Radiomics and Machine Learning in Medical Imaging (11 papers) and Cancer Immunotherapy and Biomarkers (9 papers). The work is most often cited by research in Genetics (6.1k citations), Cancer Research (3.8k citations), Oncology (2.9k citations), Molecular Biology (5.8k citations) and Immunology (1.5k citations). Howard Colman has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Adam L. Cohen, Kenneth Aldape, Burt G. Feuerstein, Anjan Misra, Janice Nigro, Erik P. Sulman, Ken Aldape, Heidi Phillips, Liliana Soroceanu and Robert Soriano. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, Cancer Research and Stem Cells.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact